FHFelicia Scaggs Huang

Felicia Scaggs Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Felicia Scaggs Huang has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Staphylococcus aureus mupirocin susceptibility testing in a neonatal intensive care unit reveals horizontal transmission of a highly resistant strain

    by Andrea L. Ankrum, David B. Haslam, Joel E. Mortensen, Felicia Scaggs-Huang

    Objectives: Determine the prevalence of Staphylococcus aureus mupirocin resistance in a Neonatal Intensive Care Unit (NICU) population to inform decolonization regimen decisions. Investigate highly resistant methicillin-resistant S. aureus (MRSA) isolates for stain relatedness and horizontal transmission events. Methods: Mupirocin susceptibility of S. aureus isolates from nares of NICU patients was evaluated by E-test. Strain relatedness of nine MRSA isolates with high-level mupirocin resistance along with one blood isolate was analyzed by whole-genome sequencing. An epidemiological investigation was performed using electronic medical record data. Results: Overall S. aureus mupirocin resistance was 12.7% (89/102) with MRSA isolates exhibiting a 38% (11/29) resistance rate. All sequenced MRSA isolates were the same strain and possessed the mupA gene. Five patients tested positive on admission, four patients acquired the strain in our NICU, and one patient’s acquisition status was indeterminant. Conclusions: Overall, mupirocin resistance among S. aureus isolates was low; however, MRSA isolates demonstrated a higher-than-expected resistance rate. A highly resistant strain was introduced into our NICU and transmitted to several patients, most likely due to a gap in contact precaution implementation. Simplified mupirocin susceptibility testing, clearer interpretation standards and validated alternative therapies for all age groups should be prioritized if mupirocin continues to be nationally recommended and implemented as a decolonization therapy.

  • Open Access

    Nosocomial patient exposure to a healthcare worker with active tuberculosis in a paediatric setting: a contact investigation

    by G. Griffin, P. Manning-Courtney, P.A. Hagedorn, J. Schaffzin, F. Scaggs Huang

  • Open Access

    A Pediatric Case of Rapidly Progressing Disseminated Human Adenovirus C1 Infection with Multiorgan Failure and Evidence of Intra-Host Variation

    by William Otto, Lindsey Rickerman, Maria Deza Leon, Felicia Scaggs Huang, Krithivasan Sankaranarayanan, Christopher Dandoy, Daryl M. Lamson, Adriana E. Kajon

    A strain of human adenovirus type C1 was isolated from multiple anatomical compartments in a pediatric patient with late-onset Pompe disease. Over a period of 23 days from the appearance of fever and respiratory symptoms until death, disease progression was rapid with severe disseminated disease and complications that included respiratory distress, liver failure, cardiac dysfunction, and hemophagocytic lymphohistiocytosis. Detected viral DNAemia peaked at log10 9.52 copies/mL on the last hospitalization day. Next-generation whole-genome sequencing with depth > 2700 reads/position identified the virus as closely related to the prototype strain Adenoid 71 isolated in the US in 1953, and to strains circulating worldwide in recent years. Sequence data analysis revealed the presence of intra-host single nucleotide variants (iSNV) at low frequency in the isolates recovered from a nasopharyngeal swab, blood, urine, and stool specimens obtained during the last three days of life and from lung, liver, and kidney tissue obtained at autopsy. Evidence of iSNVs was found in only three coding regions (E1A, DNA polymerase, and pVII). Different variant combinations were found in different anatomical compartments. The contribution of intrahost genetic diversity to HAdV-associated disease development and progression warrants investigation.

  • Open Access

    Mycobacterium chelonae outbreak investigation at a quaternary pediatric hospital following the opening of a LEED-certified critical care tower: where does water sustainability intersect with infection control?

    by Andrea L. Ankrum, Silvia M. Caceres, Michael Torsell, Elaine Epperson, Vinicius Calado Nogueira de Moura, Jennifer J. Gilick, Michael Strong, Qingyun Liu, Matthew J. Strand, Rachel N. Wilsey, et al.

    Objective: Investigate the increased incidence of Mycobacterium chelonae positive respiratory cultures in hospitalized patients. Design: Apply the Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria (HALT NTM) toolkit to an outbreak investigation of M. chelonae. Setting: Quaternary-care pediatric hospital and medical center in the United States with a recently opened LEED-certified critical care tower. Patients: Adult and pediatric patients with M. chelonae positive respiratory cultures between June 2022 and January 2024. Methods: An epidemiological investigation involving clinical and laboratory practices, water management, building construction and renovation projects. Environmental sampling of air vents, water sources and endoscope reprocessing equipment was performed. M. chelonae isolates recovered from patients and the environment were analyzed using whole genome sequencing and compared for relatedness. Results: Three clusters of matching environmental and patient isolates were identified. The most common environmental source of M. chelonae was ice/water dispensers with 40% positivity of sampled units. The critical care tower’s water system performance and metrics were suboptimal, leading to four physical remediation activities along with a hyperchlorination treatment. Conclusions: Recent and ongoing construction along with the implementation of a LEED-certified, low-flow water system in a new critical care tower provided enhanced opportunities for M. chelonae exposure at point of use locations such as ice/water dispensers. More national infection prevention and control guidance is needed to address the infection risks from water sustainability efforts and construction activities in healthcare facilities.


  • Effectiveness of COVID-19 vaccination to prevent health care personnel absences: A single site experience

    by Felicia Scaggs Huang, Qing Duan, Abraham Araya, Anna Sheets, Joshua K. Schaffzin

  • Open Access

    An outbreak after all: Cutibacterium acnes among pediatric patients with cerebrospinal fluid diversion device infections highlights gaps in guidelines

    by Felicia Scaggs Huang, Cameron Griffin, Matthew Fenchel, Melanie DuBose, Andrea Ankrum, Joshua K. Schaffzin

    Objective: Cutibacterium acnes is normal skin flora but can cause sterile implant infections. We investigated a cluster of seven patients with C. acnes in anaerobic cerebrospinal fluid (CSF) cultures in November 2020. Further analysis identified a missed outbreak, highlighting ambiguity in diagnosis of indolent organisms in the 2017 IDSA meningitis guidelines. Design: Outbreak investigation. Setting: Quaternary pediatric facility. Patients: A case was defined as a hospitalized patient with C. acnes isolated from CSF culture from January 1, 2016 to December 31, 2022. Methods: We defined comparison periods based on timing of C. acnes culture positivity as 1) pre-outbreak (2016–2020), 2) outbreak (2020–2021), and 3) post-outbreak (2022). Rates of C. acnes positive cultures per 1000 CSF cultures and rate ratios were calculated by comparison periods. Results: We identified 9 positive C. acnes CSF cultures among 7 cases November 10–27, 2020, all with at least 1 CSF diversion device. The anaerobic culture media was substituted at the time of case cluster. In 2021, the culture media was implemented permanently with no increase in C. acnes culture positivity. The rate of C. acnes positive CSF cultures and rate ratio increased in the outbreak period (p=0.01) compared to pre-outbreak and post-outbreak periods. There was no difference between the pre- and post-outbreak periods. Conclusions: Retrospective analysis of CSF culture data led to reclassifying a C. acnes pseudo-outbreak as a true outbreak in CSF diversion devices at our institution. Clearer guidance is needed to delineate the role of C. acnes in CSF diversion device infections.


  • Open Access

    Adherence to Personal Protective Equipment practices during the COVID-19 pandemic: A pilot study

    by Taryn B. Amos, Cameron Griffin, Joshua K. Schaffzin, Andrea Ankrum, Felicia Scaggs Huang


  • Infectious Diseases Evaluation of the Child With Suspected Hemophagocytic Lymphohistiocytosis

    by Maria Deza Leon, William R Otto, Lara Danziger-Isakov, Ashish Kumar, Felicia Scaggs Huang

    Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of excessive and maladaptive inflammation. In this review, we discuss how the clinical and laboratory features of HLH overlap with infection and propose a diagnostic and treatment strategy to identify patients with infections mimicking HLH.


  • Open Access

    Effectiveness of a Staphylococcus aureus mupirocin decolonization protocol in a neonatal intensive care unit

    by Andrea Ankrum, Felicia Scaggs Huang, Joshua Schaffzin

    Background:Staphylococcus aureus infections are a significant cause of morbidity in neonatal intensive care units (NICUs), and they are typically preceded by nasal colonization. Mupirocin decolonization protocols as an infection prevention tool can halt S. aureus outbreaks and prevent infections. We examined the effect of a mupirocin treatment protocol on S. aureus incidence, prevalence, decolonization, and infections in a level IV NICU. Methods: We conducted a retrospective before-and-after observational study from June 1, 2018, to May 31, 2020. Beginning June 1, 2019, patients identified with either methicillin-sensitive or -resistant S. aureus (MSSA or MRSA) received mupirocin ointment to bilateral nares 3 times daily for 5 days. Patients with central lines or surgical incisions were treated every 30 days. All NICU patients were screened weekly unless positive for MRSA. We defined MSSA decolonization as 3 consecutive negative screens following mupirocin treatment. We calculated monthly S. aureus incidence as any new positive per 1,000 patient days and monthly prevalence as a percentage of the average daily number of patients with S. aureus per the average monthly census. Total number of infections were compared. Statistical significance was determined using a 2 sample proportions test and P < .05. Decolonization was calculated as percentage of occurrences among treated patients. Results: Overall, 190 patients received mupirocin; 142 patients received 1 course and 48 received 2 or more courses. There was no difference in incidence of MSSA (P = .09), but prevalence decreased from 18.8% to 14.4% (P < .05) (Fig. 1). Of 66 patients with MSSA, 35% were decolonized. An additional mupirocin treatment for 16 of these patients had a 50% decolonization rate. For MRSA, incidence decreased from 0.24 to 0.20 (P = .36) and prevalence decreased from 21.9% to 18.6% (P < .05) (Fig. 1). There was no statistical difference in the number of total S. aureus infections (P = .91) or when stratified by MSSA (P = .72) or MRSA (P = .82). In the postmupirocin population, there were 5 MRSA and 7 MSSA infections. Of the MSSA-infected patients, 6 remained colonized at the time of infection. Conclusions: Implementing a single mupirocin treatment course for S. aureus decolonization in NICU was only effective in one-third of patients and had no effect on infection occurrence. Changes in incidence and prevalence could be confounded by other infection prevention practices. Further study is needed to determine whether continued screening and additional mupirocin treatment could improve effectiveness of S. aureus decolonization programs. Disclosure: None